Zhitong Hong Kong Stock Shareholder Equity Disclosure | November 4
Gemdale PPT and CSTONE PHARMA-B conducted the latest shareholder equity disclosure on November 4, 2025. | Stock Name | Institution Name | Nature | Shares Before Change | Shares After Change | Shareholding Ratio | | -------------------- | ------------------ | ---------- | ---------------------- | --------------------- | -------------------- | | Gemdale PPT | Loh Lian Huat | Good Position | 11.226 million shares | 12.248 million shares | 0.07% (latest) | 0.07% (previous) | | CSTONE PHARMA-B | Yang Jianxin | Good Position | 70.943 million shares | 71.162 million shares | 4.82% (latest) | 4.81% (previous) | Note: Changes in shareholding may be due to rights issues, consolidations, splits, etc. Please verify against actual circumstances
According to the Zhitong Finance APP, GEMDALE PPT (00535) and CSTONE PHARMA-B (02616) conducted their latest shareholder equity disclosure on November 4, 2025.
| Stock Name | Institution Name | Nature | Shares Held Before Change | Shares Held After Change | Shareholding Ratio |
|---|---|---|---|---|---|
| GEMDALE PPT (00535) | Loh Lian Huat | Good Position | 11.226 million shares | 12.248 million shares | 0.07% (latest) 0.07% (previous) |
| CSTONE PHARMA-B (02616) | Yang Jianxin | Good Position | 70.943 million shares | 71.162 million shares | 4.82% (latest) 4.81% (previous) |
Note: Changes in the number of shares held may be due to rights issues, consolidations, stock splits, etc. Please pay attention to verify against actual circumstances
